MAPT and Alzheimer disease: Researchers have utilized this tool to predict aggregation propensities for proteins implicated in AD (tau, amyloid-β), PD (α-synuclein), and Type 2 diabetes (islet amyloid polypeptide, IAPP) [72,138].